Atea Pharmaceuticals Stock Target Price and Analyst Consensus

AVIR -  USA Stock  

USD 25.11  0.42  1.65%

The current analyst and expert consensus on Atea Pharmaceuticals is Buy, with 0 strong sell and 3 strong buy opinions. The current projected Atea Pharmaceuticals target price consensus is 33.0 with 2 analyst opinions. The most common way Atea Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Atea Pharmaceuticals executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Atea Pharmaceuticals. We encourage you to use your own analysis of Atea Pharmaceuticals to validate this buy or sell advice. Atea Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Atea Pharmaceuticals target price to derive its highest and lowest estimates based on projected price volatility of 2.828. Please continue to Macroaxis Advice on Atea Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Search Analyst Recommendations 

As of 07/26/2021, Gross Profit is likely to drop to about 43.5 M. In addition to that, Profit Margin is likely to drop to -0.22. As of 07/26/2021, Receivables is likely to grow to about 919.1 K. Also, Accounts Payable is likely to grow to about 134.9 K

Atea Pharmaceuticals Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Atea Pharmaceuticals target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Atea Pharmaceuticals target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Number of Opinions4
Lowered Outlook0
Raized Outlook0
Most Atea Pharmaceuticals analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Atea Pharmaceuticals stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Atea Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Atea Pharmaceuticals Target Price Projection

Atea Pharmaceuticals' current and average target prices are 25.11 and 33.00, respectively. The current price of Atea Pharmaceuticals is the price at which Atea Pharmaceuticals is currently trading. On the other hand, Atea Pharmaceuticals' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Atea Pharmaceuticals Market Quote on 26th of July 2021

Low Price24.75Odds
High Price25.89Odds


Target Price

Analyst Consensus On Atea Pharmaceuticals Target Price

Low Estimate31.0Odds
High Estimate35.0Odds
Number of Analysts2
Standard Deviation2.828


Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Atea Pharmaceuticals and the information provided on this page.

Atea Pharmaceuticals Analyst Ratings

Atea Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Atea Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Atea Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. Atea Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.

Average Consensus Estimates

About Atea Pharmaceuticals Target Price Projections

Atea Pharmaceuticals's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Atea Pharmaceuticals and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Atea Pharmaceuticals depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Atea Pharmaceuticals
 2015 2016 2020 2021 (projected)
PPandE Turnover37.135.649.342.93
Long Term Debt to Equity0.0064940.0053480.006150.007743

Additional Atea Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Atea Pharmaceuticals is a key component of Atea Pharmaceuticals valuation and have some predictive power on the future returns of a Atea Pharmaceuticals.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Atea Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Atea Pharmaceuticals in the context of predictive analytics.
LowEstimated ValueHigh
LowReal ValueHigh
Estimates (3)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Atea Pharmaceuticals. Your research has to be compared to or analyzed against Atea Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Atea Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Atea Pharmaceuticals.

Currently Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Driverless Cars
Invested over 200 shares
Invested few shares
Macroaxis Index
Invested over 50 shares
Invested over 60 shares
Invested one share
Please continue to Macroaxis Advice on Atea Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Atea Pharmaceuticals information on this page should be used as a complementary analysis to other Atea Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Atea Pharmaceuticals Stock analysis

When running Atea Pharmaceuticals price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Bond Directory
Find actively traded corporate debentures issued by US companies
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
The data published in Atea Pharmaceuticals' official financial statements usually reflect Atea Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Atea Pharmaceuticals. For example, before you start analyzing numbers published by Atea Pharmaceuticals accountants, it's critical to develop an understanding of what Atea Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Pharmaceutical Products space in which it operates.
Please note, the presentation of Atea Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Atea Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Atea Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Atea Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Atea Pharmaceuticals' management to manipulate its earnings.